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Thiols such as cysteine and dithiothreitol are substrates for the ADP-ribosyltransferase ctivity of pertussis toxin. When 
cysteine was incubated with NAD ÷ and toxin at pH 7.5, a product containing ADP-ribose and cysteine (presumably 
ADP-ribosylcysteine) was isolated by high:performance liquid chromatography, and characterized byits composition and 
release of AMP with phosphodiesterase. Cysteine has a Km of 105 mM at saturating NAD + concentration. The ability 
of thiols to act as a substrate is one explanation for the very high concentrations (250 mM or greater) that have been 
observed to enhance the apparent NAD glycohydrolase activity of the toxin. 
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1. INTRODUCTIQN 
Pertussis toxin (review [1]) is a pathologically 
important protein secreted by Bordetella pertussis, 
the bacterium that causes whooping cough. The 
toxin is composed of five different subunits named 
S-1 to S-5 on the basis of decreasing molecular 
mass. The S-1 subunit, or A protomer, is an ADP- 
ribosyltransferase and also has NAD glyco- 
hydrolase activity. The remaining subunits con- 
stitute the B protomer, and are responsible for 
binding to a cell surface receptor and facilitating 
the entry of S-1 into the cell. Once within the cell, 
S-1 catalyses the transfer of ADP-ribose from 
NAD + to Gi, a GTP-binding regulatory protein of 
the adenylate cyclase complex. The toxin gene has 
been sequenced [2,3]. 
A Michaelis constant (Km) of 25/zM has been 
measured for NAD + in the NAD glycohydrolase 
reaction catalysed by the toxin, and generally 
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assumed to be a model for the ADP-ribosyltrans- 
ferase [4]. It purports to represent the breakdown 
of NAD + with water as the only acceptor for ADP- 
ribose. It has been found that this reaction is ac- 
celerated by sulphydryl compounds such as dithio- 
threitol, presumably because it is required for 
reducing a disulphide bond in the S-1 subunit, 
making it enzymically active [5]. However, the 
concentrations of thiol used have been much 
higher than is normally needed for activation (e.g. 
cholera toxin is analogous in many ways but needs 
only 10 mM at most). Concentrations of 250 mM 
dithiothreitol have often been used [4,6]. 
Here, we show that thiol reagents are substrates 
for the ADP-ribosyltransferase reaction of the tox- 
in, and that is why high concentrations accelerate 
the apparent glycohydrolase activity. 
2. MATERIALS AND METHODS 
2.1. Materials 
Pertussis toxin was from the Public Health Laboratory Ser- 
vice Centre for Applied Microbiology and Research (Porton, 
Wiltshire, England) and was purified by the method of Irons 
and MacLennan [7]. [nicotinarnide-4-3H]NAD + was from 
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Fig. 1. Effect of NAD ÷ concentration on the ADP-ribosyltrans- 
ferase activity of pertussis toxin at 250 mM dithiothreitol. 
Reaction velocity is measured as pmol nicotinamide released/h 
per sample. 
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Fig.2. Effect of cysteine concentration on the ADP-ribosyl- 
transferase activity of pertussis toxin at 100/zM NAD +. Reac- 
tion velocity as in fig. 1. 
Amersham International, and [adenine-2,8-3H]NAD + and 
[UJ4C}cysteine from DuPont. Snake venom phosphodiesterase 
was from Sigma. 
2.2. Assay of apparent NAD + hydrolysis 
NAD + glycohydrolase activity was measured by the method 
of Moss and Vaughan [8], in which [3H]nicotinamide released 
from [nicotinamide-4-3H]NAD + is measured by ion-exchange 
chromatography on Dowex AG-1X resin. The reaction mixture 
typically contained 50 mM phosphate buffer, 250 mM dithio- 
threitol, 1 mg/ml ovalbumin and 12/~g toxin (pH 7.5) in a final 
volume of 300/A. 
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Fig.3. HPLC traces. 1, injection point; 2, ADP-ribose; 3, 
putative ADP-ribosylcysteine; 4, NAD+; 5, AMP; 6, nicotin- 
amide. 
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2.3. Separation of reaction products by high-performance 
liquid chromatography 
Reaction products were filtered through an Amicon OM-10 
filter to remove protein, and applied to a reverse-phase ODS- 
HYP 2734 column (25 cmx 4.6 ram) in 10 mM NHaH2PO4, 
10% MeOH (pH 3.5) run at 1 ml/min, using Altex equipment. 
The eluate was monitored by its absorbance at 254 nm. 5 drop 
fractions (about 100/zl) were collected and, where appropriate, 
assayed for 14C and 3H by scintillation counting. 
3. RESULTS 
3. I. Effect of  thiol on the rate o f  NAD + 
hydrolysis 
The rate of release of nicotinamide catalysed by 
pertussis toxin in the presence of 250 mM dithio- 
threitol was assayed as in [8]. Typical results are 
shown in fig. 1, and give a Michaelis constant, Kin, 
of 30/zM for NAD +. 
The rate of nicotinamide release was also 
assayed at different concentrations of several other 
thiols, e.g. mercaptoethanol, g utathione and cys- 
teine. In all cases, increasing concentrations of 
thiol increased the rate of reaction until saturation 
was achieved at concentrations of the order of 
300 mM, suggesting that the thiols were substrates. 
Fig.2 shows a conventional kinetic analysis of the 
effect of cysteine concentration at fixed high 
NAD + concentration (100/~M, near saturating). 
This suggests that cysteine is acting as a substrate 
of the reaction, showing a Km of 105 raM. 
3.2. Isolation of  an ADP-ribose-sulphydryl 
compound 
Fig.3a shows the separation by hig h - 
performance liquid chromatography of ADP- 
ribose, NAD +, AMP and nicotinamide. The 
products of an incubation of 50/~M NAD + with 
pertussis toxin in the presence of 250 mM cysteine 
for 4 h at 30°C were applied to such a column, and 
ADP-ribose and NAD + identified in the eluate 
(fig.3b). (Nicotinamide is much retarded in this 
system and thus hard to detect at low concentra- 
tion; cysteine cannot be detected at 254 nm.) 
Radiolabelled compounds [adenine-2,8-SH]NAD + 
(2.5/zCi//zmol in the mixture) and [u-X4C]cysteine 
(1.3/~Ci/mmol) were incorporated into the reac- 
tion mixture, the experiment repeated, and the 
solution applied to the HPLC column. Fig.4 shows 
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Fig.4. Elution of radioactive material from the HPLC column. 1, cysteine; other peaks as in fig.3. ( ) 3H; ( - - - )  14C. 
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the result. It is clear that the unknown product 
contains both ~4C and 3H, and so is a compound 
made from both cysteine and the adenine moiety 
of NAD +. This peak was collected and freeze- 
dried. Fig.3c shows an HPLC run of a sample. 
3.3. Treatment with phosphodiesterase 
If the unknown compound is ADP-ribosylcys- 
teine, then treatment with snake-venom phospho- 
diesterase should release AMP, and phosphoribo- 
sylcysteine as reaction products. A sample of the 
purified material (as shown in fig.3c) was in- 
cubated with phosphodiesterase from Crotalus 
durissus terrificus (20/~g/ml) in 50 mM phosphate 
buffer (pH 7.5) for 5 h at 37°C, and applied to a 
column as shown in fig.3d. Several peaks were 
identified: one corresponding to the starting 
material and labelled with both 3H and ~4C, one 
labelled with 3H and corresponding in position to 
AMP, and another not previously seen but labelled 
with 14C and in a position compatible with its being 
phosphoribosylcysteine. 
4. DISCUSSION 
These experiments show that thiols such as cys- 
teine are substrates for pertussis toxin; that is the 
reason why such high concentrations have been 
needed to achieve the maximum rate of breakdown 
of NAD +. The Km value obtained for the apparent 
NAD glycohydrolase reaction of 30/~M is in 
reasonable agreement with published values [4], 
that were determined at high concentrations of di- 
thiothreitol. The Km for cysteine at saturating con- 
centration of NAD + was 105 mM, a high value but 
one that does show that cysteine can be a useful 
substrate at the high concentrations that have been 
used [4,6]. 
By using NAD + and cysteine labelled with dif- 
ferent radionuclides, we have been able to show 
that pertussis toxin can catalyse the formation of 
a compound containing both the adenine moiety of 
NAD and the carbon atoms of cysteine. Although 
this does not prove a particular structure for the 
product, it is reasonable to suppose that it is ADP- 
ribosylcysteine with a covalent bond between the 
C-1 atom of ribose and the sulphur atom of cys- 
teine. Its elution position from the HPLC column 
is compatible with this structure, and treatment 
with phosphodiesterase liberated AMP as would 
be predicted. 
Cysteine was identified as the substrate for 
ADP-ribosylation by toxin on the GTP-binding 
protein transducin (a model for Gi) by West et al. 
[9], who also suggested that a glycosyl-cysteine 
bond had been formed. The observation that cys- 
teine can also be an acceptor for ADP-ribose in 
vitro makes their observation (which was well sup- 
ported experimentally) less surprising than it ap- 
peared at first sight. 
These experiments show that thiols can have two 
roles in the activity of pertussis toxin in vitro: as an 
activator of the toxin by reduction of a disulphide 
bond, and as a substrate for the toxin-catalysed 
reaction. 
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